Very early researchNot Yet RecruitingNCT07172178What this trial is testingΓδ T-PD-1 Ab Cells in the Treatment of Malignant MeningiomaWho this might be right forMalignant Meningioma Nanjing Medical University 12
Early research (Phase 1)Looking for participantsNCT05477927What this trial is testingDual-targeting VEGFR1 and PD-L1 CAR-T for Pleural, Peritoneal, or Leptomeningeal MetastasesWho this might be right forMalignant Peritoneal EffusionMalignant AscitesSerous Cavity Metastatises+1 more Sichuan University 40
Early research (Phase 1)Study completedNCT01082926What this trial is testingPhase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2Who this might be right forAnaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Meningioma+11 more City of Hope Medical Center 6
Early research (Phase 1)Study completedNCT01119599What this trial is testingRO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaWho this might be right forAcoustic SchwannomaAdult Anaplastic (Malignant) MeningiomaAdult Anaplastic Astrocytoma+26 more National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Study completedNCT00025675What this trial is testingGefitinib in Treating Patients With Recurrent or Progressive CNS TumorsWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 105
Large-scale testing (Phase 3)Study completedNCT00750009What this trial is testingPersonalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Case Comprehensive Cancer Center 583
Testing effectiveness (Phase 2)Study completedNCT00003939What this trial is testingEcteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaWho this might be right forBrain and Central Nervous System TumorsEndometrial CancerGastrointestinal Stromal Tumor+3 more European Organisation for Research and Treatment of Cancer - EORTC 132
Testing effectiveness (Phase 2)UnknownNCT00008164What this trial is testingUmbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic AnemiaWho this might be right forChildhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more Herbert Irving Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT00019630What this trial is testingLiposomal Doxorubicin in Treating Children With Refractory Solid TumorsWho this might be right forChildhood Soft Tissue SarcomaChildhood Liver CancerBone Cancer+2 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00010049What this trial is testingImatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or MeningiomaWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 105
Early research (Phase 1)Study completedNCT03434262What this trial is testingSJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Ganglioglioma+53 more St. Jude Children's Research Hospital 68
Not applicableEnded earlyNCT01234805What this trial is testingYoga Therapy in Treating Patients With Malignant Brain TumorsWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Meningioma+20 more Wake Forest University Health Sciences 9
Testing effectiveness (Phase 2)Study completedNCT00003270What this trial is testingChemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Roswell Park Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT03507244What this trial is testingConcurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid TumorsWho this might be right forLeptomeningeal Metastasis The First Hospital of Jilin University 34
Testing effectiveness (Phase 2)Study completedNCT00003887What this trial is testingLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Fred Hutchinson Cancer Center
Not applicableLooking for participantsNCT05746325What this trial is testingTumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung CancerWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Malignant Neoplasm in the Leptomeninges+2 more Mayo Clinic 5
Testing effectiveness (Phase 2)UnknownNCT00008307What this trial is testingCombination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic DisordersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Herbert Irving Comprehensive Cancer Center 52
Large-scale testing (Phase 3)Study completedNCT00004230What this trial is testingCaptopril in Treating Patients Undergoing Bone Marrow or Stem Cell TransplantationWho this might be right forCancer Northwestern University 35
Not applicableUnknownNCT04728568What this trial is testingExploratory Study of PD-1 Neoadjuvant Treatment of Recurrent MeningiomaWho this might be right forMeningioma, Malignant Beijing Tiantan Hospital 15
Testing effectiveness (Phase 2)Study completedNCT00237627What this trial is testingDoxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast CancerWho this might be right forBreast CancerLeukemiaLymphoma+3 more UNC Lineberger Comprehensive Cancer Center 107